Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent.
- Published In:
- Drug testing and analysis, 17(11), 2210-2219 (2025)
- Authors:
- Liu, Lu(2), Wang, Zhanliang, Zhao, Lingyu, Zhou, Xinmiao, Zhang, Lisi
- Database ID:
- RPEP-12227
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-12227APA
Liu, Lu; Wang, Zhanliang; Zhao, Lingyu; Zhou, Xinmiao; Zhang, Lisi. (2025). Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent.. Drug testing and analysis, 17(11), 2210-2219. https://doi.org/10.1002/dta.3931
MLA
Liu, Lu, et al. "Method Development of Pegmolesatide for Doping Analysis: A Novel Synthetic Erythropoietin-Mimetic Agent.." Drug testing and analysis, 2025. https://doi.org/10.1002/dta.3931
RethinkPeptides
RethinkPeptides Research Database. "Method Development of Pegmolesatide for Doping Analysis: A N..." RPEP-12227. Retrieved from https://rethinkpeptides.com/research/liu-2025-method-development-of-pegmolesatide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.